Zibotentan

From WikiMD.org
Jump to navigation Jump to search

Zibotentan (pronounced as zee-boh-ten-tan) is a type of medication specifically designed as an endothelin receptor antagonist. It is primarily used in the treatment of prostate cancer.

Etymology

The term "Zibotentan" is a coined name, like many pharmaceutical drugs, and does not have a specific etymology.

Usage

Zibotentan is used in the treatment of hormone-resistant prostate cancer. It works by blocking the action of a natural substance called endothelin-1 which is often found in high levels in men with prostate cancer. By blocking the action of endothelin-1, Zibotentan can slow the growth of the cancer and may also prevent the growth of new blood vessels within the cancer.

Related Terms

  • Endothelin receptor antagonist: A type of medication that blocks the action of endothelin-1.
  • Prostate cancer: A type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.
  • Hormone-resistant prostate cancer: A type of prostate cancer that is not responding to the hormone therapy.
  • Endothelin-1: A protein that constricts blood vessels and raises blood pressure. It is often found in high levels in men with prostate cancer.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski